WO2007099396A3 - Antibiotic kit and composition and uses thereof - Google Patents
Antibiotic kit and composition and uses thereof Download PDFInfo
- Publication number
- WO2007099396A3 WO2007099396A3 PCT/IB2006/003975 IB2006003975W WO2007099396A3 WO 2007099396 A3 WO2007099396 A3 WO 2007099396A3 IB 2006003975 W IB2006003975 W IB 2006003975W WO 2007099396 A3 WO2007099396 A3 WO 2007099396A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agent
- weight
- pressurized product
- concentration
- antibiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006339311A AU2006339311A1 (en) | 2005-06-07 | 2006-06-07 | Antibiotic kit and composition and uses thereof |
EP06847249A EP1919449A2 (en) | 2005-06-07 | 2006-06-07 | Antibiotic kit and composition and uses thereof |
CA002611577A CA2611577A1 (en) | 2005-06-07 | 2006-06-07 | Antibiotic kit and composition and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68824405P | 2005-06-07 | 2005-06-07 | |
US60/688244 | 2005-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007099396A2 WO2007099396A2 (en) | 2007-09-07 |
WO2007099396A3 true WO2007099396A3 (en) | 2008-03-13 |
Family
ID=38459394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/003975 WO2007099396A2 (en) | 2005-06-07 | 2006-06-07 | Antibiotic kit and composition and uses thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1919449A2 (en) |
AU (1) | AU2006339311A1 (en) |
CA (1) | CA2611577A1 (en) |
WO (1) | WO2007099396A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US9050253B2 (en) | 2003-08-04 | 2015-06-09 | Foamix Pharmaceuticals Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9161916B2 (en) | 2007-12-07 | 2015-10-20 | Foamix Pharmaceuticals Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US9492412B2 (en) | 2002-10-25 | 2016-11-15 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
EP1556009B2 (en) | 2002-10-25 | 2021-07-21 | Foamix Pharmaceuticals Ltd. | Cosmetic and pharmaceutical foam |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
WO2008075207A2 (en) * | 2006-04-04 | 2008-06-26 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
EP2029106A2 (en) * | 2006-06-07 | 2009-03-04 | Foamix Ltd. | Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
CN101662935A (en) * | 2007-05-04 | 2010-03-03 | 宝洁公司 | Antimicrobial compositions, products, and methods of use |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
CA2712120A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
US20110196040A1 (en) * | 2008-02-15 | 2011-08-11 | Action Medicines S.L. | Skin Penetration Enhancing Systems for Polar Drugs |
WO2009124386A1 (en) * | 2008-04-07 | 2009-10-15 | Interface Biologics Inc. | Combination therapy for the treatment of bacterial infections |
EP2174650A1 (en) * | 2008-10-08 | 2010-04-14 | Polichem SA | Modified release emulsions for application to skin or vaginal mucosa |
FR2943914A1 (en) * | 2009-04-06 | 2010-10-08 | Fabre Pierre Dermo Cosmetique | MOISTURE BOTTLE COMPRISING A PHARMACEUTICAL COMPOSITION |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
WO2011061155A1 (en) * | 2009-11-17 | 2011-05-26 | Bayer Consumer Care Ag | Antifungal formulations and their use |
PT2504353T (en) | 2009-11-23 | 2018-10-18 | Cubist Pharmaceuticals Llc | Lipopeptide compositions and related methods |
EP2725904A4 (en) | 2011-06-28 | 2014-12-10 | Medicis Pharmaceutical Corp | High dosage mucoadhesive metronidazole aqueous-based gel formulations their use to treat bacterial vaginosis |
EP2753326A4 (en) | 2011-09-09 | 2015-04-15 | Cubist Pharm Inc | Methods for treating intrapulmonary infections |
BR112014004454A2 (en) | 2011-09-21 | 2017-03-28 | Stem Cell Medicine Ltd | beta-lactam compounds to enhance t-cell mediated immune responses |
BR112014005864A2 (en) | 2011-09-21 | 2017-03-28 | Stem Cell Medicine Ltd | beta-lactam compounds to treat diabetes |
SG190466A1 (en) * | 2011-11-18 | 2013-06-28 | Agency Science Tech & Res | Methods for diagnosis and/or prognosis of ovarian cancer |
CN102526398A (en) * | 2012-01-17 | 2012-07-04 | 肖文辉 | Externally-used traditional Chinese medicinal preparation for treating chronic pelvic inflammation |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
PE20160048A1 (en) | 2013-03-15 | 2016-02-12 | Merck Sharp & Dohme | ANTIBIOTIC COMPOSITIONS OF CEFTOLOZANE |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
US20140274993A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane-tazobactam pharmaceutical compositions |
WO2015035376A2 (en) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
GB201415776D0 (en) | 2014-09-05 | 2014-10-22 | Singh Ishwar And Taylor Edward | New antibacterial products |
JP6793715B2 (en) | 2015-03-23 | 2020-12-02 | バイオファーミクス・インコーポレイテッドBioPharmX, Inc. | Tetracycline skin pharmaceutical composition |
WO2017009870A1 (en) * | 2015-07-13 | 2017-01-19 | Ahir Pramodbhai N | A topical formulation for chronic skin and hair disease |
CN105726545A (en) * | 2016-03-22 | 2016-07-06 | 史飞 | Cephradine for prevention and/or treatment of TOPK (T-LAK cell-originated protein kinase) activity abnormally increased skin inflammations by inhibition of TOPK |
CN106045875A (en) * | 2016-06-25 | 2016-10-26 | 仇颖超 | Preparation method of occrycetin |
MX2020012139A (en) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Compositions and methods for treating rosacea and acne. |
AU2017314833A1 (en) | 2017-02-24 | 2019-07-25 | The Regents Of The University Of California | Compositions and methods for promoting hair growth with mpc inhibitors |
AU2018294351B2 (en) | 2017-06-30 | 2022-12-22 | The Regents Of The University Of California | Compositions and methods for modulating hair growth |
WO2019067860A1 (en) * | 2017-09-29 | 2019-04-04 | The Regents Of The University Of California | Compositions and methods for modulating hair growth |
CN111920812B (en) * | 2020-07-10 | 2022-09-20 | 深圳市臻质医疗科技有限公司 | Application of calcium channel inhibitor oxylipine in osteoarthritis |
CN114632075B (en) * | 2022-05-19 | 2022-07-15 | 奥信阳光(北京)药业科技有限公司 | Voriconazole aerosol inhalation and application |
CN115463091B (en) * | 2022-10-27 | 2023-04-07 | 新基元(北京)医药科技有限公司 | Minocycline foaming agent with improved stability |
CN115739051A (en) * | 2022-11-30 | 2023-03-07 | 浙江工业大学 | Hydrophobic membrane and preparation method and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004037225A2 (en) * | 2002-10-25 | 2004-05-06 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
WO2004064833A1 (en) * | 2003-01-24 | 2004-08-05 | Connetics Australia Pty Ltd. | Clindamycin phosphate foam |
US20040241099A1 (en) * | 2003-05-28 | 2004-12-02 | Popp Karl F. | Foamable pharmaceutical compositions and methods for treating a disorder |
WO2005011567A2 (en) * | 2003-08-04 | 2005-02-10 | Foamix Ltd. | Foam carrier containing amphiphilic copolymeric gelling agent |
WO2005018530A2 (en) * | 2003-08-25 | 2005-03-03 | Foamix Ltd. | Penetrating pharmaceutical foam |
-
2006
- 2006-06-07 CA CA002611577A patent/CA2611577A1/en not_active Abandoned
- 2006-06-07 AU AU2006339311A patent/AU2006339311A1/en not_active Abandoned
- 2006-06-07 EP EP06847249A patent/EP1919449A2/en not_active Withdrawn
- 2006-06-07 WO PCT/IB2006/003975 patent/WO2007099396A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004037225A2 (en) * | 2002-10-25 | 2004-05-06 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
WO2004064833A1 (en) * | 2003-01-24 | 2004-08-05 | Connetics Australia Pty Ltd. | Clindamycin phosphate foam |
US20040241099A1 (en) * | 2003-05-28 | 2004-12-02 | Popp Karl F. | Foamable pharmaceutical compositions and methods for treating a disorder |
WO2005011567A2 (en) * | 2003-08-04 | 2005-02-10 | Foamix Ltd. | Foam carrier containing amphiphilic copolymeric gelling agent |
WO2005018530A2 (en) * | 2003-08-25 | 2005-03-03 | Foamix Ltd. | Penetrating pharmaceutical foam |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9492412B2 (en) | 2002-10-25 | 2016-11-15 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
US9050253B2 (en) | 2003-08-04 | 2015-06-09 | Foamix Pharmaceuticals Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9161916B2 (en) | 2007-12-07 | 2015-10-20 | Foamix Pharmaceuticals Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
Also Published As
Publication number | Publication date |
---|---|
AU2006339311A1 (en) | 2007-09-07 |
EP1919449A2 (en) | 2008-05-14 |
WO2007099396A2 (en) | 2007-09-07 |
CA2611577A1 (en) | 2007-09-07 |
AU2006339311A2 (en) | 2007-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007099396A3 (en) | Antibiotic kit and composition and uses thereof | |
WO2007023396A3 (en) | Vasoactive kit and composition and uses thereof | |
WO2007012977A3 (en) | Steroid kit and foamable composition and uses thereof | |
WO2007072216A3 (en) | Kit and composition of imidazole with enhanced bioavailability | |
WO2007007208A3 (en) | Nonsteroidal immunomodulating kit and composition and uses thereof | |
WO2007007198A3 (en) | Retinoid immunomodulating kit and composition and uses thereof | |
WO2005076697A3 (en) | Cosmetic and pharmaceutical foam with solid matter | |
WO2007054818A3 (en) | Foamable vehicle and pharmaceutical compositions thereof | |
WO2007085899A3 (en) | Foamable arthropocidal composition for tropical application | |
WO2009090495A3 (en) | Oil and liquid silicone foamable carriers and formulations | |
WO2007085902A3 (en) | Foamable composition combining a polar solvent and a hydrophobic carrier | |
WO2009007785A3 (en) | Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses | |
WO2008038147A3 (en) | Foamable vehicle comprising dicarboxylic acid or dicarboxylic acid ester and pharmaceutical compositions thereof | |
AU1275395A (en) | Novel foaming compositions, particularly for rectal foams, and resulting foams | |
CA2362030A1 (en) | Foaming cosmetic products | |
AU2003244450A1 (en) | Formulations for inhalation | |
WO2008064293A3 (en) | Carbon filled pressurized container and method of making same | |
AU5858501A (en) | Aerosol container for formulations of salmeterol xinafoate | |
WO2004084858A3 (en) | Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants | |
CA2188236A1 (en) | Azeotrope-like compositions of 1,1,1,3,3-pentafluoropropane and 2-methyl butane | |
KR960701817A (en) | GAS GENERATOR COMPOSITION, PROCESS FOR PRODUCING TABLET THEREFROM, AND TRANSPORTATION METHOD | |
WO2008089413A3 (en) | Urea foam | |
CA2554433A1 (en) | Aerosol spray resistant to discoloration | |
WO2001049779A3 (en) | Composition which can be foamed from a pressurized container for producing insulating foams | |
JO3395B1 (en) | Aerosol for controlling insect pests |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2611577 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006847249 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006339311 Country of ref document: AU Ref document number: 564272 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4925/KOLNP/2007 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2006339311 Country of ref document: AU Date of ref document: 20060607 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006339311 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006847249 Country of ref document: EP |